Myeloid-derived suppressor cells adhere to physiologic STAT3- vs STAT5-dependent hematopoietic programming, establishing diverse tumor-mediated mechanisms of immunologic escape.
about
Modification of the tumor microenvironment as a novel target of renal cell carcinoma therapeuticsInteractome analysis of myeloid-derived suppressor cells in murine models of colon and breast cancerDefinitive activation of endogenous antitumor immunity by repetitive cycles of cyclophosphamide with interspersed Toll-like receptor agonists.Dasatinib promotes the expansion of a therapeutically superior T-cell repertoire in response to dendritic cell vaccination against melanoma.Myeloid-derived suppressor cells in glioma.Tumour-induced immune suppression: role of inflammatory mediators released by myelomonocytic cells.Myeloid-derived suppressor cell heterogeneity in human cancers.Recent immunomodulatory strategies in transplantation.Highlights on mechanisms of drugs targeting MDSCs: providing a novel perspective on cancer treatment.Immunosuppressive therapy in allograft transplantation: from novel insights and strategies to tolerance and challenges.Myeloid-derived suppressor cells as effectors of immune suppression in cancer.Myeloid derived suppressor cell infiltration of murine and human gliomas is associated with reduction of tumor infiltrating lymphocytes.The Measure of DAMPs and a role for S100A8 in recruiting suppressor cells in breast cancer lung metastasis.Expansion of myeloid derived suppressor cells correlates with number of T regulatory cells and disease progression in myelodysplastic syndrome.Immune tolerance in liver disease.Immunological Investigations. Letter from the editor.
P2860
Q28393614-C290B969-D6EC-47A8-9688-6AAE4D27B95CQ34956969-AC199DC0-9EFE-4181-9AFE-B80EAB86A7DBQ37536440-77E45FCE-B5E1-47D2-A9C6-130C908FCD6DQ37698857-9861DB9B-376A-4E24-AD84-2F77E3337525Q38161536-0A955E59-3723-42AE-ACDC-DB440ABBA332Q38193589-32584219-E7A1-4D64-8C78-23CD2D175294Q38223250-EA9C0857-391D-4069-8D57-4BA0C842CD72Q38258157-ED30719B-58CD-4CD8-A980-8EFD23FE1A38Q38398117-E4337B7D-4035-43A0-AAA9-237B208D4C4AQ38544028-E0920A58-E2BA-4091-8EF0-D19728462B7DQ38864758-F41BCF39-9A09-44F2-A9AB-E297FC1E5C86Q38920881-8E382FF1-7ACE-4411-BF0B-234D2C98FC67Q38953395-AF40A81A-8931-4731-BCB4-430D16E500AAQ39279547-BB72C9D2-C4B4-42DD-A3FB-BB270109DFF4Q43077728-4D874B8A-1F8D-4E60-9900-D5ED366CD5E0Q44817360-FF1E9DB1-FFEF-4C9D-AB4C-6216D0F5CD6C
P2860
Myeloid-derived suppressor cells adhere to physiologic STAT3- vs STAT5-dependent hematopoietic programming, establishing diverse tumor-mediated mechanisms of immunologic escape.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Myeloid-derived suppressor cel ...... hanisms of immunologic escape.
@en
Myeloid-derived suppressor cel ...... hanisms of immunologic escape.
@nl
type
label
Myeloid-derived suppressor cel ...... hanisms of immunologic escape.
@en
Myeloid-derived suppressor cel ...... hanisms of immunologic escape.
@nl
prefLabel
Myeloid-derived suppressor cel ...... hanisms of immunologic escape.
@en
Myeloid-derived suppressor cel ...... hanisms of immunologic escape.
@nl
P2093
P2860
P1476
Myeloid-derived suppressor cel ...... hanisms of immunologic escape.
@en
P2093
Anna Lucia Dominguez
Brian I Rini
Christopher D Spencer
Dustin B McCurry
James H Finke
Jennifer S Ko
Jessica E Gorman
Judy M Bradley
Latha B Pathangey
Patricia A Rayman
P2860
P304
P356
10.3109/08820139.2012.703745
P577
2012-01-01T00:00:00Z